These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 453808)

  • 1. Effects of embryonic and neonatal disruption of developing central dopaminergic systems.
    Hoffmann PC; Erinoff L; MacPhail RC; Seiden LS; Heller A
    Appl Neurophysiol; 1979; 42(1-2):84-7. PubMed ID: 453808
    [No Abstract]   [Full Text] [Related]  

  • 2. On the relation between haloperidol-induced alterations in DA release and DA metabolism in rat striatum.
    Moleman P; Bruinvels J; van Valkenburg CF
    Life Sci; 1978 Aug; 23(6):611-5. PubMed ID: 692284
    [No Abstract]   [Full Text] [Related]  

  • 3. Activation of striatal dopaminergic grafts by haloperidol.
    Herman JP; Choulli K; Le Moal M
    Brain Res Bull; 1985 Dec; 15(6):543-6. PubMed ID: 3936594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ingestive behavior following damage to central dopamine neurons: implications for homeostasis and recovery of function.
    Zigmond MJ; Stricker EM
    Adv Biochem Psychopharmacol; 1974; 12(0):385-402. PubMed ID: 4609140
    [No Abstract]   [Full Text] [Related]  

  • 5. Mesocortical dopamine neurons: rapid transmitter turnover compared to other brain catecholamine systems.
    Bannon MJ; Bunney EB; Roth RH
    Brain Res; 1981 Aug; 218(1-2):376-82. PubMed ID: 7272743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical effects of quipazine on rat striatal dopaminergic system.
    Ponzio F; Consolazione A; Calderini G; Achilli G; Rocchetti M; Algeri S
    Life Sci; 1981 Jul; 29(1):83-91. PubMed ID: 7266263
    [No Abstract]   [Full Text] [Related]  

  • 7. Differential sensitivity of two dopaminergic structures in rat brain to haloperidol and to clozapine.
    Wilk S; Watson E; Stanley ME
    J Pharmacol Exp Ther; 1975 Nov; 195(2):265-70. PubMed ID: 1185596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-dependent and reversible effects of lead on rat dopaminergic system.
    Memo M; Lucchi L; Spano PF; Trabucchi M
    Life Sci; 1981 Feb; 28(7):795-9. PubMed ID: 7231055
    [No Abstract]   [Full Text] [Related]  

  • 9. Developmental differences in acute nigrostriatal and mesocorticolimbic system response to haloperidol.
    Teicher MH; Barber NI; Gelbard HA; Gallitano AL; Campbell A; Marsh E; Baldessarini RJ
    Neuropsychopharmacology; 1993 Sep; 9(2):147-56. PubMed ID: 8216697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of piracetam on the central dopaminergic transmission.
    Rägo LK; Allikmets LH; Zarkovsky AM
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Dec; 318(1):36-7. PubMed ID: 6276786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulatory effect of dopamine on high-affinity glutamate uptake in the rat striatum.
    Kerkerian L; Dusticier N; Nieoullon A
    J Neurochem; 1987 Apr; 48(4):1301-6. PubMed ID: 2880932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of striatal dopamine, homovanillic acid and 3,4-dihydroxyphenylacetic acid in the hypothermia and catalepsy induced by haloperidol.
    Massotti M
    Pharmacol Res Commun; 1977 Apr; 9(4):381-9. PubMed ID: 559310
    [No Abstract]   [Full Text] [Related]  

  • 13. Haloperidol inhibits the disappearance of acidic dopamine metabolites from rat striatum.
    Moleman P; Bruinvels J; van Valkenburg CF
    J Pharm Pharmacol; 1978 Sep; 30(9):583-5. PubMed ID: 29101
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of dopaminergic antagonists on striatal DOPAC concentrations and alpha-methyl-p-tyrosine-induced decline of dopamine following intrastriatal injections of kainic acid.
    Wuerthele SM; Moore KE
    J Pharm Pharmacol; 1979 Mar; 31(3):180-2. PubMed ID: 34696
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of 6-hydroxydopamine treatments on active avoidance responding: evidence for involvement of brain dopamine.
    Cooper BR; Breese GR; Grant LD; Howard JL
    J Pharmacol Exp Ther; 1973 May; 185(2):358-70. PubMed ID: 4703827
    [No Abstract]   [Full Text] [Related]  

  • 16. Haloperidol prevents the methamphetamine-induced apomorphine subsensitivity of dopamine metabolism in rat striatum.
    Kashihara K; Fukuda K; Sato M; Otsuki S
    Neurosci Res; 1987 Jun; 4(5):428-32. PubMed ID: 3670749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the relevance of preferential increases of mesolimbic versus striatal dopamine turnover for the prediction of antipsychotic activity of psychotropic drugs.
    Waldmeier PC; Maître L
    J Neurochem; 1976 Aug; 27(2):589-97. PubMed ID: 989496
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term effects of haloperidol, Clozapine, and methadone on rat striatal cholinergic and dopaminergic dynamics.
    Ladinsky H; Consolo S; Samanin R; Algeri S; Ponzio F
    Adv Biochem Psychopharmacol; 1980; 24():259-65. PubMed ID: 7405665
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of development of thermoregulatory function on the biochemical assessment of the ontogeny of neonatal dopaminergic neuronal activity.
    Horwitz J; Heller A; Hoffmann PC
    Brain Res; 1982 Mar; 235(2):245-52. PubMed ID: 7188327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cholinergic effect on the dopamine turnover in the rat corpus striatum].
    Oelszner W; Funk KF; Schwarzenfeld IV; Staib AH; Westermann KH
    Acta Biol Med Ger; 1975; 34(4):647-53. PubMed ID: 1189838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.